SRTD biotech raised an undisclosed amount in Seed funding led by High-Tech Gründerfonds to expand operations and R&D efforts.
PRIVATEDec 02, 2024
Round Type
Seed
DürenBiotechnologyHealth CareTherapeutics
Investors
Business AngelsHigh Tech Gründerfonds
Description
SRTD biotech, based in Jülich, Germany, has raised Seed funding to further develop its RNA-based therapeutics. The funding round was led by High-Tech Gründerfonds along with business angels.
Who to call at SRTD biotech, and when
A new round usually means SRTD biotech is about to hire and buy. The teams that reach out first get the meeting.
An alert the day SRTD biotech raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at SRTD biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SRTD biotech. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
SRTD biotech
Location
Düren, North Rhine-Westphalia, Germany
About
SRTD biotech is a company based in Jülich, Germany, specializing in RNA-based therapeutics. It focuses on developing therapies that target diseased cells using selectively expressed RNAs, or seRNAs. The company aims to create innovative treatments for liver cancer and expand its research and development in cancer therapeutics. Founded by Dr. Bernd Hoffmann and Dr. Heribert Bohlen, SRTD biotech is dedicated to advancing the field of RNA therapeutics.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SRTD biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DürenBiotechnologyHealth CareTherapeutics